Objective: The aim of this study was to evaluate the osteoconductive potential of BoneCeramic TM on bone healing in rat calvaria 5-mm defects. Therefore, the biomaterial tested was found to be favorable to fill bone defects for the reporting period analyzed.
Introduction
Functional recovery of the jaws using dental implants requires a minimum thickness and height of ridges 1, 5, 15 . Several factors culminate in the absence of alveolar bone, which then becomes a limiting factor for implant placement. This usually occurs in patients who have suffered dentoalveolar trauma, traumatic tooth extractions, dental congenital absence, or other diseases involving the maxilla and mandible 2, 9, 17 . The current trend is to develop and use biomaterials that accelerate or at least allow normal and complete repair of bone defects, thus reducing postoperative failure rate 7, 22 . The objective of tissue engineering is to generate an osteoconductive biomaterial that is conducive to bone healing or even superior to bone grafts 17 .
Synthetic bone substitutes with osteoconductive property, such as calcium phosphate-based ceramic biomaterials, have been investigated 10, 11, 20 . Recently, Miramond, et al. 14 (2014) showed that isolated biphasic Frenken, et al. 6 (2010), Mardas, et al. 12 (2011), and Wang, et al. 23 (2014) showed that BC is a bone substitute with osteoconductive properties, favorable We propose the null hypothesis that the bone area of newly formed bone defects filled with autogenous bone or BC will not show a statistical difference.
Material and methods
Experimental design into three groups (n=8 each) and euthanized at one of the two time-points: 14 and 28 days after surgery.
They were kept in cages and fed with balanced feed (NUVILAB, Curitiba, PR, Brazil) containing 1.4% Ca and 0.8% P and provided water ad libitum in the our institution.
A bone defect (5 mm) was induced in the calvaria of each animal as follows:
•Clot Group (CG, n=16): The bone defect was not filled with some biomaterial (the defect remain empty until clot stabilization);
•Autogenous Bone Group (AG, n=16): The 5-mm bone defect was filled with autogenous bone (collected from the calvaria of the same animal). After the defect was made, the bone was particulate and used to fill the defect;
•Bone Ceramic Group (BCG, n=24): The 5-mm bone defect was filled with alloplastic bone (Straumann).
For this group, eight additional animals were operated upon and euthanized after 42 days to verify the longterm behavior of this group.
Experimental surgery
The animals were subjected to preoperative
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To finish the procedure, the soft tissues (including the periosteum) were carefully repositioned and Calvaria of rats were removed and fixed in 10% formaldehyde solution for 48 hours, washed in running water for 24 hours, decalcified in 20% ethylenediaminetetraacetic acid for 6 weeks followed by alcohol dehydration, and cleared in xylene.
Subsequently, the calvariae were longitudinally cut in half, separating the bone defects. The specimens obtained were embedded in paraffin and cut using a microtome into 6-μm-thick sections and placed on slides. Some slides were stained with hematoxylin and eosin (HE) while others were used for immunohistochemical analysis.
Prior to performing the analyses, samples were coded in such a way that only the supervisor was aware of the group corresponding to each slide.
Subsequently, the examiner performed the analyses in a blinded manner.
Histometric analysis
After staining the slides in HE (Merck & Co., Inc.), measurements were performed using a ×1.6 magnifying glass (LeicaR DMLB, Heerbrugg, Switzerland) and a lens with ×20 magnification (Leica Microsystems Aristoplan, Leitz, Benshein, Germany).
These were coupled to an image-capturing camera 
Statistical analysis
Statistical analysis was performed using Sigma Plot software 12.3 (San Jose, CA, USA) as per standards from previous studies 8, 11, 16 . The comparative analysis of biomaterials was performed using 2-criteria variance analysis, after having performed the test of normality (Kolmogorov-Smirnov) and the equal variance test. Specific analysis for BCG (14, 28 , and 42 days) was performed using analysis of variance (ANOVA) to a criterion 25 after having performed the normality test (Kolmogorov-Smirnov) and equal variance test.
Analysis of the time periods was performed using paired t-test 8, 16 and the normality test (Shapiro-Wilk)
was used. For all analyses, the Tukey test was used as a post-test. We adopted a significance level of p<0.05.
Immunohistochemical analysis
The The AG group showed full compatibility bone formation after 28 days; however, the defect was not fully filled in the CG as expected (Figure 9 ). The average BMD for the CG, AG, and BCG was 498, 850, and 935 HU at 14 days and 485, 1797, and 1337 HU at 28 days, respectively. Moreover, the BMD for BCG was 1554 HU at 42 days ( Figure 10 ).
Discussion
We rejected the null hypothesis that the newly Therefore, further studies should be conducted to quantify this protein through molecular analysis using real-time polymerase chain reaction (RT-PCR), to better understand these findings.
In a consequence for RUNX-2 labeling, and osteoblastic differentiation, OC labeling showed that newly formed bone mineralization after preparation of the bone defects was similar for the biomaterials used 
Conclusion
Therefore, within the limits of this in vivo study,
we may conclude that the tested biomaterial (BC) was favorable to fill bone defects until the end of the reporting period analyzed.
